Ingersoll Rand Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Ingersoll Rand Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,939	2,375	2,690	2,018	3,973	5,152	5,916	6,876	7,235	7,651
Cost of revenue	1,223	1,478	1,677	1,239	2,568	3,164	3,591	3,994	4,065	4,315
Gross profit	717	898	1,013	778	1,405	1,989	2,326	2,882	3,170	3,336
Research and development	22	26	24	22	58	74	91.3	108	117	114
Selling, general and administrative	415	446	435	410	789	1,028	1,096	1,273	1,344	1,439
Operating income	104	109	443	194	59.6	566	817	1,164	1,300	1,145
Interest expense	170	141	99.6	88.4	111	87.7	103	157	213	254
Other non-operating income	3.6	3.4	7.2	4.7	8.1	44	29.2	37	48.9	44.6
Pre-tax income	-63.2	-113	350	110	-45.4	513	742	1,031	1,133	935
Income tax	-31.9	-131	80.1	12.9	11.4	-21.8	150	240	263	219
Income from continuing operations				97.3	-57.7	521	590	779	839
Net income to minority interests	5.3	0.1	0	0	0.9	2.5	3.8	6.4	7.7	7.4
Net income	-36.6	18.4	269	159	-33.3	563	605	779	839	581
EBITDA	276	283	623	341	472	988	1,250	1,623	1,782	1,650
EPS, basic	-0.25	0.10	1.34	0.78	-0.09	1.36	1.49	1.92	2.08	1.46
EPS, diluted	-0.25	0.10	1.29	0.76	-0.09	1.34	1.47	1.90	2.06	1.45
Shares, basic (weighted)	149	182	202	204	383	415	405	405	403	398
Shares, diluted (weighted)	149	188	209	209	383	421	410	409	407	401

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	256	393	221	506	1,751	2,110	1,613	1,596	1,541	1,249
Receivables	442	536	525	459	862	949	1,122	1,234	1,335	1,518
Inventory	444	495	524	503	717	854	1,025	1,001	1,055	1,173
Other current assets	47.2	39.5	60.7	76.8	195	187	207	220	232	308
Total current assets	1,189	1,464	1,331	1,544	3,862	4,115	3,967	4,050	4,164	4,248
Property, plant and equipment	358	363	357	327	609	649	624	711	842	930
Lease right-of-use assets				53.8	143	102	127	164	227	236
Goodwill	1,155	1,228	1,290	1,093	5,583	5,982	6,064	6,610	8,148	8,484
Intangible assets	1,470	1,431	1,368	1,255	3,797	3,913	3,579	3,611	4,373	4,240
Other non-current assets	143	135	140	212	329	469	509	549	457	356
Total assets	4,316	4,621	4,487	4,628	16,059	15,155	14,766	15,564	18,010	18,297
Accounts payable	215	270	340	323	536	671	779	801	844	996
Accrued liabilities	259	271	249	244	709	741	859	996	972	1,069
Deferred revenue				51.7	165	242	306	331	319	347
Short-term debt	24.5	20.9	7.9	7.6	40.4	38.8	36.5	30.6	3.1	1.4
Total current liabilities	498	562	596	575	1,499	1,468	1,674	1,827	1,819	2,066
Long-term debt	2,754	2,019	1,664	1,604	3,859	3,402	2,716	2,693	4,754	4,783
Lease liabilities				41	90.5	61	80.4	117	166	168
Other non-current liabilities	182	226	190	229	344	310	361	434	294	463
Total liabilities	4,044	3,144	2,811	2,759	6,869	6,083	5,509	5,717	7,765	8,143
Total debt	2,778	2,040	1,672	1,611	3,900	2,778	2,748	2,723	4,756	4,785
Paid-in capital	1,222	2,275	2,283	2,302	9,310	9,409	9,477	9,551	9,634	9,700
Retained earnings	-596	-578	-309	-141	-176	379	951	1,697	2,504	3,053
Treasury stock	-19.4	-23	-53	-36.8	-33.3	-748	-985	-1,241	-1,494	-2,519
Other comprehensive income	-342	-200	-247	-256	14.2	-41.6	-252	-228	-469	-148
Shareholders' equity	266	1,477		1,870	9,120	9,002	9,196	9,784	10,179	10,090
Minority interests	5.9	0		0	69.8	69.7	61.4	62.9	66.3	64.2
Total equity	272	1,477	1,676	1,870	9,190	9,071	9,257	9,847	10,245	10,154
Total liabilities and equity	4,316	4,621	4,487	4,628	16,059	15,155	14,766	15,564	18,010	18,297
Shares outstanding	149	196	198	205	419	408	405	403	403	391

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-31.3	18.5	269	159	-32.4	565	609	785	846	589
Depreciation and amortization	173	174	180	147	413	422	433	459	482	506
Stock-based compensation	0	175	2.8	18.7	47.5	87.2	78.9	51.9	58.8	53
Deferred income tax	-84.4	-249	4	-21.3	-83.1	-104	-85.8	-76.9	-33.1	-79.4
Change in receivables	-48.8	-65.7	13.2	-14.5	52.4	-62.5	-195	-48.6	-45.1	-59.1
Change in inventory	23.5	-22.7	-13	27.4	159	-134	-226	117	39.8	-26.1
Change in payables	58.1	39.9	69.6	44.2	-43.4	118	120	-23.9	13.3	78.7
Cash from operations	166	201	445	343	914	628	865	1,377	1,397	1,356
Capital expenditures	-74.4	-56.8	-52.2	-37.9	-42	-64.1	-94.6	-105	-149	-136
Acquisitions	-18.8	-18.8	-186	-12	9	-975	-247	-963	-2,959	-525
Cash from investing	-82.1	-60.8	-235	-54.3	-37.9	-1,029	-337	-1,061	-3,108	-661
Debt issued	1	2,011	0	0	1,980	0	0	1,490	3,297	0
Debt repaid	-26.5	-2,879	-338	-32.6	-1,619	-436	-656	-1,518	-1,243	0
Stock issued	3.3	894	0	0	22.7	23.7	19.3	30.3	32.2	15.3
Share buybacks	-14.1	-3.6	-40.7	-18.6	-2.1	-737	-261	-263	-261	-1,018
Dividends paid				0	0	-8.2	-32.4	-32.4	-32.3	-31.8
Cash from financing	-43	-17.4	-373	-11.5	329	-1,157	-954	-338	1,708	-1,054
Exchange rate effect	-13	15.2	-8.6	6.8	40.3	-14.1	-70	3.1	-50.8	66.3
Net change in cash	27.5	138	-172	284	1,245	359	-497	-17.5	-54.3	-292
Free cash flow	91.2	144	392	305	872	564	771	1,272	1,248	1,220
Interest paid	154	143	98.5	85.6	98.7	79.8	95.2	101	209	249
Income taxes paid	35.5	55.5	103	61.6	106	428	182	302	277	269

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $76.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.8%	Gross profit / revenue.
Operating margin	18.1%	Operating income / revenue.
EBITDA margin	24.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.2%	Pre-tax income / revenue.
Net margin	12.1%	Net income / revenue.
FCF margin	15.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.0%	Cash from operations / revenue.
Effective tax rate	20.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.3%	Net income / average total assets.
Return on invested capital (ROIC)	8.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	18.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.6%	Capital expenditures / revenue.
D&A / revenue	6.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	8.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-12.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	80.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-7.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	9.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	28.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-30.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-29.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-0.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-2.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	16.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-2.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	16.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-0.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	2.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.62x	Current assets / current liabilities.
Quick ratio	1.01x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.44x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.47x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	26.2%	Total debt / total assets.
Liabilities / assets	43.7%	Total liabilities / total assets.
Net debt	$3.60B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.82x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.58x	Operating income / interest expense.
Working capital	$1.63B	Current assets - current liabilities.
Goodwill and intangibles / assets	69.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.44B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.44x	Revenue / average total assets.
Fixed asset turnover	8.76x	Revenue / average property, plant and equipment.
Inventory turnover	3.68x	Cost of revenue / average inventory.
Days inventory	99 days	365 x average inventory / cost of revenue.
Receivables turnover	5.24x	Revenue / average receivables.
Days sales outstanding	70 days	365 x average receivables / revenue.
Days payables	73 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	95 days	Days inventory + days sales outstanding - days payables.
FCF conversion	127.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.45	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.27	Revenue / diluted weighted shares.
FCF per share	$3.11	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.44	Cash from operations / diluted weighted shares.
Book value per share	$25.97	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$6.22	Tangible book value / shares outstanding.
Cash per share	$2.99	(Cash + short-term investments) / shares outstanding.
Payout ratio	3.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	2.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	69.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$29.52B	Share price x shares outstanding.
Enterprise value	$33.11B	Market cap + total debt - cash - short-term investments.
P/E	30.8x	Market cap / net income. Only when net income is positive.
P/S	3.72x	Market cap / revenue.
P/B	2.90x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	24.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	21.9x	Market cap / cash from operations, when positive.
EV/Sales	4.17x	Enterprise value / revenue.
EV/EBIT	23.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	27.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.1%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.1%	Dividends paid over the period / market cap.
Shareholder yield	3.0%	(Dividends paid + share buybacks) / market cap.

What was Ingersoll Rand Inc.'s revenue in fiscal 2025?

Ingersoll Rand Inc. reported revenue of $7.65B for fiscal 2025, 5.7% higher than the year before.

Was Ingersoll Rand Inc. profitable in fiscal 2025?

Yes. Net income was $581.4M, a net margin of 7.6%.

How much free cash flow did Ingersoll Rand Inc. generate in fiscal 2025?

Cash from operations of $1.36B minus capital expenditures of $135.6M left free cash flow of $1.22B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Ingersoll Rand Inc.